Glycan-based drugs, therapies and biomarkers
AssigneeB&H Biotechnologies, LLC
InventorHuiru Wang
Life of this patent
Estimating the term…
Abstract
The present disclosure discloses simple and efficient glycan- or carbohydrate-based processes or methods for the rapid identification of biological markers and therapeutic targets especially glycan-related targets of infectious diseases, cancers, autoimmune diseases, allergies, inflammation, toxicity, obesity and/or other disorders of humans, animals, plants and other organisms. Therefore, novel methods and products for the diagnosis, prevention, and treatment of such diseases obtainable based on these therapeutic targets can be developed.
Claims11
A method of treating or preventing viral diarrhea, or an infectious disease caused by an influenza virus, a Newcastle disease virus, or a rotavirus in a patient, the method comprising administering to the patient a pharmaceutical composition comprising:
- N-acetylneuraminic acid;
- and
- a compound of the structure:
- wherein
- R is hydrogen, alkoxy, alkyl, cycloalkyl, substituted alkyl, substituted cycloalkyl, aryl, substituted aryl, ether, thioester, disulfide ester, disulfide methyl, methionine, or phenol.
Dependencies are inferred from the claim text.